Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Sotera Health Company
  6. Summary
    SHC   US83601L1026

SOTERA HEALTH COMPANY

(SHC)
  Report
Delayed Nasdaq  -  04:00:00 2023-05-26 pm EDT
14.32 USD   +1.42%
05/16Transcript : Sotera Health Company Presents at RBC Capital Markets Global Healthcare Conference 2023, May-16-2023 04:35 PM
CI
05/12Sotera Health to Present at the 2023 RBC Capital Markets Global Healthcare Conference
GL
05/11The Law Offices of Frank R. Cruz Announces Investigation of Sotera Health Company (SHC) on Behalf of Investors
BU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/22/2023 05/23/2023 05/24/2023 05/25/2023 05/26/2023 Date
14.6(c) 14.57(c) 14.3(c) 14.12(c) 14.32(c) Last
1 964 843 1 206 954 989 788 1 128 380 621 902 Volume
-0.27% -0.21% -1.85% -1.26% +1.42% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 1 069 M - -
Net income 2023 123 M - -
Net Debt 2023 1 853 M - -
P/E ratio 2023 32,9x
Yield 2023 -
Sales 2024 1 162 M - -
Net income 2024 171 M - -
Net Debt 2024 1 705 M - -
P/E ratio 2024 23,7x
Yield 2024 -
Capitalization 4 046 M 4 046 M -
EV / Sales 2023 5,52x
EV / Sales 2024 4,95x
Nbr of Employees 3 000
Free-Float 95,7%
More Financials
Company
Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. The Company operates through three segments: Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets... 
Read more
More about the company
Ratings of Sotera Health Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SOTERA HEALTH COMPANY
05/16Transcript : Sotera Health Company Presents at RBC Capital Markets Global Hea..
CI
05/12Sotera Health to Present at the 2023 RBC Capital Markets Global Healthcare Conference
GL
05/11The Law Offices of Frank R. Cruz Announces Investigation of Sotera Health Company (SHC)..
BU
05/04Barclays Adjusts Price Target on Sotera Health to $20 From $21, Maintains Overweight Ra..
MT
05/04RBC Cuts Price Target on Sotera Health to $18 From $19, Maintains Outperform Rating
MT
05/03SOTERA HEALTH CO Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/03Transcript : Sotera Health Company, Q1 2023 Earnings Call, May 03, 2023
CI
05/03Sotera Health's Q1 Adjusted Earnings, Revenue Fall; Reaffirms Full-Year 2023 Outlook
MT
05/03Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Reports Q1 EPS $0.13, vs. Street Est of..
MT
05/03Earnings Flash (SHC) SOTERA HEALTH SERVICES LLC Posts Q1 Revenue $220.6M, vs. Street Es..
MT
05/03Sotera Health Reports First-Quarter 2023 Results
GL
05/03Sotera Health Reports First-Quarter 2023 Results
AQ
05/03Sotera Health Company Reports Earnings Results for the First Quarter Ended March 31, 20..
CI
05/03Sotera Health Company Re-Affirms Revenue Guidance for the Year 2023
CI
04/18Sotera Health Announces First-Quarter 2023 Earnings Release Date
GL
More news
News in other languages on SOTERA HEALTH COMPANY
05/03Sotera Health enregistre une baisse de ses bénéfices ajustés et de son chiffre d'affair..
05/03Sotera Health Company publie ses résultats pour le premier trimestre clos le 31 mars 20..
05/03Sotera Health Company réaffirme ses prévisions de revenus pour l'année 2023
03/21Sotera Health Company augmente sa facilité de crédit renouvelable de 76,3 millions de d..
02/28Sotera Health Company - Bénéfices ajustés et augmentation des revenus au 4e trimestre
More news
Analyst Recommendations on SOTERA HEALTH COMPANY
More recommendations
ETFs positioned on SOTERA HEALTH COMPANYETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
First Trust Health Care AlphaDEX Fund ETF - USD0.78%-5.63%United_States
Invesco S&P MidCap 400 Equal Weight ETF - USD0.47%-0.35%United_States
Syntax Stratified MidCap ETF - USD0.41%-0.52%United_States
First Trust Mid Cap Growth AlphaDEX Fund ETF - USD0.27%-0.37%United_States
SoFi Next 500 ETF - USD0.17%0.00%United_States
More ETFs positioned on SOTERA HEALTH COMPANY
Chart SOTERA HEALTH COMPANY
Duration : Period :
Sotera Health Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SOTERA HEALTH COMPANY
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 14,32 $
Average target price 18,50 $
Spread / Average Target 29,2%
EPS Revisions
Managers and Directors
Michael B. Petras Chief Executive Officer
Michael Francis Biehl Chief Financial Officer
Robert G. Hauzie Chief Information Officer
Sean Laurence Cunningham Independent Director
Dave Anthony Donnini Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SOTERA HEALTH COMPANY71.91%4 046
CVS HEALTH CORPORATION-27.42%86 716
HCA HEALTHCARE, INC.10.19%72 736
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY23.75%25 491
LABORATORY CORPORATION OF AMERICA HOLDINGS-8.44%19 102
QUEST DIAGNOSTICS INCORPORATED-14.49%14 983
-40% off: Our subscriptions help you unlock hidden opportunities!
Subscribe
fermer